The authors further found that KDM4D enhanced glycolysis to promote CRC progression by activating the hypoxia-inducible factor 1 signaling pathway through interaction with the transcription factors SRY-Box Transcription Factor 9 and c-Fos, as well as hypoxia-inducible factor 1α [144]. Here, KDM4D is linked to colorectal carcinoma.